Tower Research Capital (TRC)’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Tower Research Capital (TRC)’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-751	Closed	-$10.8K	–	5165
2025 Q3	$10.8K	Buy	+751	New	+$10.7K	﹤0.01%	3947
2024 Q3	–	Sell	-30	Closed	-$461	–	5716
2024 Q2	$461	Hold	30	–	–	﹤0.01%	5322
2024 Q1	$492	Sell	30 -602	-95%	-$9.49K	﹤0.01%	5467
2023 Q4	$9.26K	Sell	632 -2,132	-77%	-$29.8K	﹤0.01%	4414
2023 Q3	$39.8K	Buy	2,764 +2,734	+9,113%	+$42.6K	﹤0.01%	2745
2023 Q2	$493	Sell	30 -304	-91%	-$4.96K	﹤0.01%	5618
2023 Q1	$6K	Buy	+334	New	+$5.38K	﹤0.01%	4825

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Tower Research Capital (TRC)'s BMEZ Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of BlackRock Health Sciences Trust II (BMEZ) in Q4 2025, closing a stake of 751 shares — an estimated $10.8K sold.

Tower Research Capital (TRC) first reported a position in BMEZ in Q1 2023 and held it in 7 quarters. The position peaked at $39.8K in Q3 2023. 86 funds tracked by Wall St. Rank hold BMEZ as of Q4 2025.

Tower Research Capital (TRC) reported no remaining BlackRock Health Sciences Trust II position as of Q4 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 751 BlackRock Health Sciences Trust II shares in Q4 2025, an estimated $10.8K.
Tower Research Capital (TRC) first reported a position in BlackRock Health Sciences Trust II in Q1 2023 and held it in 7 quarters.
Tower Research Capital (TRC)'s BlackRock Health Sciences Trust II position peaked at $39.8K in Q3 2023.
86 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.